| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2023 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 03/14/2023 |
4
| THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Exercised 20,000 options to buy
@ $0.4591, valued at
$9.2k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 06/03/2022 |
4
| THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 375,000 options to buy
@ $0.4591, valued at
$172.2k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Bought 10,000 shares
@ $0.7474, valued at
$7.5k
|
|
| 01/07/2022 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 2,214 options to buy
@ $13.19, valued at
$29.2k
|
|
| 08/18/2021 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $13.69, valued at
$102.7k
|
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 1,314 options to buy
@ $17.93, valued at
$23.6k
|
|
| 10/27/2020 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $13.52, valued at
$101.4k
|
|
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Exercised 10,000 options to buy
@ $2.44, valued at
$24.4k
|
|
| 04/03/2020 |
4
| THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 150,000 options to buy
@ $7.05, valued at
$1.1M
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 200,000 options to buy
@ $13.58, valued at
$2.7M
|
|
| 01/02/2020 |
3
| THOMAS FRANK E (See Remarks) has filed a Form 3 on Orchard Therapeutics plc |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2019 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 6,073 options to buy
@ $10.67, valued at
$64.8k
|
|
| 06/07/2018 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 20,000 options to buy
@ $6.79, valued at
$135.8k
|
|
| 06/06/2018 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 6,073 options to buy
@ $11.54, valued at
$70.1k
|
|
| 11/01/2017 |
3
| THOMAS FRANK E (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/01/2016 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 12,000 options to buy
@ $5.99, valued at
$71.9k
|
|
| 03/01/2016 |
4
| THOMAS FRANK E (President & COO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 7,417 shares
@ $27.01, valued at
$200.3k
Paid exercise price by delivering 1,361 shares
@ $27.01, valued at
$36.8k
Paid exercise price by delivering 458 shares
@ $27.01, valued at
$12.4k
Paid exercise price by delivering 515 shares
@ $26.28, valued at
$13.5k
Granted 17,000 shares
@ $0
Granted 40,000 options to buy
@ $25.18, valued at
$1M
|
|
| 08/21/2015 |
4
| THOMAS FRANK E (President & COO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 2,363 shares
@ $61.71, valued at
$145.8k
|
|
| 08/07/2015 |
4
| THOMAS FRANK E (President & COO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 15,000 shares
@ $66.85, valued at
$1M
Exercised 15,000 options to buy
@ $14.91, valued at
$223.7k
|
|
|